Literature DB >> 8205640

Global tuberculosis incidence and mortality during 1990-2000.

P J Dolin1, M C Raviglione, A Kochi.   

Abstract

Forecasts of tuberculosis morbidity and mortality are presented for the decade 1990-99. An estimated 88 million new cases of tuberculosis, of which 8 million will be attributable to HIV infection, will occur in the world during the decade; 30 million people are predicted to die of tuberculosis in the same period, including 2.9 million attributable to HIV infection. The number of new tuberculosis cases occurring each year is predicted to increase from 7.5 million (143 cases per 100,000) in 1990 to 8.8 million (152 per 100,000) in 1995 and 10.2 million (163 per 100,000) in the year 2000. In 1990, 2.5 million persons were estimated to have died of tuberculosis; at the same level of availability of treatment, it is predicted that 3.0 million tuberculosis deaths will occur in 1995 and 3.5 million in 2000. Demographic factors, such as population growth and changes in the age structure of populations, will account for 79.5% of the predicted increases in new cases. Age-specific incidence rates in sub-Saharan Africa are increasing due to the HIV epidemic and will account for the remaining 20.5% of the forecast increase in new cases. In WHO's South-East Asian Region and in Central and South America the age-specific incidence rates are expected to fall during 1990-2000, but at a slower rate than in previous years because of the expected increase in HIV seroprevalence.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Asia; Demographic Factors; Developing Countries; Diseases; Estimation Technics; Hiv Infections; Incidence; Infections; Latin America; Measurement; Mortality; Population; Population Dynamics; Tuberculosis; Viral Diseases; World

Mesh:

Year:  1994        PMID: 8205640      PMCID: PMC2486541     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries.

Authors:  C J Murray; E DeJonghe; H J Chum; D S Nyangulu; A Salomao; K Styblo
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

2.  Ten-year results during the introduction of chemotherapy for tuberculosis.

Authors:  V H Springett
Journal:  Tubercle       Date:  1971-06

3.  Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales.

Authors:  M J Humphries; S P Byfield; J H Darbyshire; P D Davies; A J Nunn; K M Citron; W Fox
Journal:  Br J Dis Chest       Date:  1984-04

4.  Tuberculosis: a global overview of the situation today.

Authors:  P Sudre; G ten Dam; A Kochi
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

5.  Secular trends of tuberculosis in western Europe.

Authors:  M C Raviglione; P Sudre; H L Rieder; S Spinaci; A Kochi
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

6.  The impact of HIV infection on the global epidemiology of tuberculosis.

Authors:  K Styblo
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1991-03

Review 7.  HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.

Authors:  J P Narain; M C Raviglione; A Kochi
Journal:  Tuber Lung Dis       Date:  1992-12
  7 in total
  148 in total

Review 1.  Global impact of human immunodeficiency virus and AIDS.

Authors:  H D Gayle; G L Hill
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 3.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

Review 4.  Tuberculosis: 8. The disease in association with HIV infection.

Authors:  J M FitzGerald; S Houston
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

Review 5.  Tuberculosis: 12. Global disease and the role of international collaboration.

Authors:  D A Enarson
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

6.  Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

Authors:  K Pehler; K M Brasky; T M Butler; R Attanasio
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

7.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

8.  Pseudodementia due to intracranial tuberculomas: an unusual presentation.

Authors:  Arvind Kumar Vaish; Nirdesh Jain; Manish Gutch; Himanshu Yadav
Journal:  BMJ Case Rep       Date:  2011-12-13

9.  Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis.

Authors:  Y O Goguet de la Salmonière; H M Li; G Torrea; A Bunschoten; J van Embden; B Gicquel
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

10.  Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Joanne Turner; Mercedes Gonzalez-Juarrero; Oliver C Turner; Ian M Orme
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.